HLG Genomics Lists on Korea's Kosdaq on July 24, Raises 55.15 Billion Won

According to E Daily, HLG Genomics, a specialty pharmaceutical company focused on active pharmaceutical ingredients (APIs) for chronic diseases, is set to list on Korea's Kosdaq exchange on July 24. The company's IPO offering price is 21,500 Korean won per share, with total fundraising of 55.15 billion won. For the fiscal year 2025, HLG Genomics reported revenue of 28.88 billion won and operating profit of 9.33 billion won.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments